78 related articles for article (PubMed ID: 8903605)
1. Growth or antigrowth: angiotensin and the endothelium.
Stoll M; Meffert S; Stroth U; Unger T
J Hypertens; 1995 Dec; 13(12 Pt 2):1529-34. PubMed ID: 8903605
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptors.
Unger T; Chung O; Csikos T; Culman J; Gallinat S; Gohlke P; Höhle S; Meffert S; Stoll M; Stroth U; Zhu YZ
J Hypertens Suppl; 1996 Dec; 14(5):S95-103. PubMed ID: 9120691
[TBL] [Abstract][Full Text] [Related]
3. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
4. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
Rosendorff C
Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
[TBL] [Abstract][Full Text] [Related]
5. Physiologic and pharmacologic implications of AT1 versus AT2 receptors.
Chung O; Stoll M; Unger T
Blood Press Suppl; 1996; 2():47-52. PubMed ID: 8913540
[TBL] [Abstract][Full Text] [Related]
6. The role of angiotensin II receptors and their antagonists in hypertension.
van Zwieten PA
Ann Ital Med Int; 2000; 15(1):85-91. PubMed ID: 10842896
[TBL] [Abstract][Full Text] [Related]
7. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
Goto K; Fujii K; Kansui Y; Iida M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
9. The role of angiotensin receptors in cardiovascular diseases.
Helin K; Stoll M; Meffert S; Stroth U; Unger T
Ann Med; 1997 Feb; 29(1):23-9. PubMed ID: 9073321
[TBL] [Abstract][Full Text] [Related]
10. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of ACE inhibitors versus AT1 blockers.
Vaughan D
Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
[TBL] [Abstract][Full Text] [Related]
15. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
18. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
19. Activation of renin-angiotensin system induces osteoporosis independently of hypertension.
Asaba Y; Ito M; Fumoto T; Watanabe K; Fukuhara R; Takeshita S; Nimura Y; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2009 Feb; 24(2):241-50. PubMed ID: 18847324
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
Sesin J; Tamargo J
Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
